Original-clinicalAtrial fibrillationEffect of pulmonary vein isolation on the distribution of complex fractionated electrograms in humans
Introduction
Over the past decade, catheter ablation therapy has assumed an increasingly important role in the treatment of patients with atrial fibrillation (AF). While pulmonary vein isolation (PVI) remains the mainstay of most catheter ablation techniques, the success rate with PVI alone has been suboptimal for patients with persistent AF (22%–75%).1, 2 Atrial substrate modification, by targeting complex fractionated electrograms (CFEs), has been described as a novel approach to AF ablation. In its original description by Nademanee and colleagues,3, 4 this technique has been performed as a stand-alone procedure for patients with paroxysmal or persistent atrial AF. More recently, targeting of CFEs has been described as an adjunct to PVI for patients with long-lasting persistent AF.5
The limitation of such an approach is that not all CFEs represent true drivers of AF and that these CFE areas are often widely distributed throughout the left atrium (LA).6, 7, 8 We recently demonstrated that in patients with persistent AF, areas of CFE measured with a commercially available software algorithm can encompass nearly 38% of the LA surface area.6 Ablation of all CFEs can therefore require an extensive amount of ablation9 that may increase complications and reduce LA function after ablation. It is also unclear whether CFEs should be targeted before or after PVI when a hybrid approach is pursued. While some investigators have described CFE ablation before PVI,10 others have targeted CFEs after PVI.11, 12 We hypothesized that PVI, by removing PV firing and wavefront collision at the PV/LA junction, would reduce the area of the LA encompassed by CFEs and therefore reduce the amount of radiofrequency (RF) ablation required when targeting CFEs as part of a hybrid ablation strategy.
Section snippets
Methods
All patients referred for an ablation procedure for persistent AF at the University of Pennsylvania were eligible for the study. Persistent AF was defined as AF persisting for greater than 1 month and refractory to at least one electrical cardioversion. The study protocol was approved by the Institutional Review Board, and all patients provided written informed consent.
Procedure
Decapolar catheters were placed in the posterior right atrium (RA) and coronary sinus. A circular mapping catheter (10-pole, 15- to 25-mm Lasso, 6-mm bipole spacing; Biosense Webster, Diamond Bar, CA) and an 8-mm or 3.5-mm irrigated-tip catheter (Biosense Webster) were introduced into the LA through the transseptal approach. Intravenous heparin was infused throughout the procedure to maintain an activated clotting time of 350–400 seconds.
All patients presented to the electrophysiology
Qualitative analysis
The qualitative analysis of CFE maps was performed by visually assessing the distribution of CFEs for the pre- and post-PVI maps. To standardize this process, the LA was divided in 24 distinct regions as described elsewhere6: distal PV (n = 4), PV–anterior LA junction (n = 4), PV–posterior LA junction (n = 4), hi-mid-low posterior LA (n = 3), hi-mid-low septum (n = 3), roof (n = 1), LA appendage (n = 1), and mitral annulus (n = 4). For every map, the presence or absence of CFEs was assessed
Quantitative analysis
For the quantitative analysis, CFE and voltage data were exported to the Matlab environment along with the 3D location of each point. The 3D geometry is composed of 1024 localization points constituting a shell onto which the CFE or voltage values are projected. Using linear interpolation, CFE and voltage values were interpolated to each of the 1024 points of the 3D anatomy. The entire LA map was then quantitatively analyzed to calculate the mean AF CL, mean LA voltage, and CFE burden (% of LA
Results
Twenty-two patients with persistent AF undergoing ablation were included in the study. Patient characteristics are summarized in Table 1. All four PVs were successfully isolated in all patients. The mean procedure duration was 5.8 ± 1.2 hours, and the mean fluoroscopy time was 99 ± 35 minutes. In two patients, AF terminated with PVI and could not be reinduced. Pre- and post-PVI mean CL CFE maps were obtained and analyzed for the 20 remaining patients.
Discussion
We demonstrated that the LA CFE burden is significantly reduced after PVI, with 56% of LA regions being CFE positive at baseline compared with only 23% post-PVI. Not surprisingly, CFE areas located in the vicinity of the PVs were most significantly attenuated by PVI. However, even LA regions remote from the PVs, which were not directly targeted with RF application, showed a 22% reduction in their CFE burden post-PVI.
These observations have important implications for ablation strategies that
Limitations
Mapping for CFEs was limited to the LA, and CFE regions in the RA or coronary sinus were not assessed systematically. It may have been of value to assess the effect of PVI on the distribution of CFEs in these areas as well. However, in the interest of optimizing procedure time (for patient comfort/safety), we chose to concentrate on the strategy that emphasized LA mapping and ablation.
CFE regions were not always targeted for ablation in the present study; therefore, we cannot determine how
Conclusions
CFEs are widely distributed in the LA of patients with persistent AF. PVI leads to a significant reduction in the LA area encompassed by CFEs both in the vicinity and remote from the PVs. Therefore, if a hybrid approach of PVI and CFE ablation is to be pursued, PVI should be performed before CFE ablation to limit extensive LA ablation.
References (19)
- et al.
Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria: safety, feasibility, and efficacy
J Am Coll Cardiol
(2005) - et al.
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate
J Am Coll Cardiol
(2004) - et al.
How to perform electrogram-guided atrial fibrillation ablation
Heart Rhythm
(2006) - et al.
A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy
Heart Rhythm
(2008) - et al.
Automated detection and characterization of complex fractionated atrial electrograms in human left atrium during atrial fibrillation
Heart Rhythm
(2007) - et al.
Interactive atrial neural network: determining the connections between ganglionated plexi
Heart Rhythm
(2007) - et al.
Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation
J Am Coll Cardiol
(2005) - et al.
Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation
Circulation
(2002) - et al.
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias
J Cardiovasc Electrophysiol
(2005)
Cited by (61)
Substrate-Based Ablation for Atrial Fibrillation
2019, Catheter Ablation of Cardiac ArrhythmiasDominant Frequency and the Mechanisms of Initiation and Maintenance of Atrial Fibrillation
2014, Cardiac Electrophysiology: From Cell to Bedside: Sixth EditionECG-I phenotyping of persistent AF based on driver burden and distribution to predict response to pulmonary vein isolation (PHENOTYPE-AF)
2022, Journal of Cardiovascular Electrophysiology
Dr. Gerstenfeld has received research grants from St. Jude Medical. These funds were not used to conduct the present study.
Dr. Roux is the recipient of the Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology from the Heart Rhythm Society.